Advanced Cancer

Showing NaN - NaN of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

Recruiting
  • Advanced Cancer
  • Relatlimab
  • +3 more
  • Duarte, California
  • +23 more
Oct 24, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

Active, not recruiting
  • Biliary Tract Cancer
  • +2 more
  • Tucson, Arizona
  • +91 more
Oct 18, 2022

Cervical Cancer, Advanced Cancer Trial in Romania, Spain, Turkey (No Further Treatment, TSR-042)

Recruiting
  • Cervical Cancer
  • Advanced Cancer
  • Elche, Alicante, Spain
  • +28 more
Oct 17, 2022

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Advanced Cancer, Metastatic Cancer Trial in Spain, United States (FS120)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • New Haven, Connecticut
  • +7 more
Aug 8, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Germany, Spain, United Kingdom (Pembrolizumab, Cisplatin,

Active, not recruiting
  • Biliary Tract Cancer
  • +3 more
  • Leipzig, Germany
  • +6 more
Jul 1, 2022

Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)

Active, not recruiting
  • Bladder Cancer
  • +3 more
  • IPI-549 (eganelisib)
  • +2 more
  • Fort Wayne, Indiana
  • +28 more
Apr 1, 2022

Advanced Cancer, Metastatic Cancer Trial in Spain (FS222)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • Pamplona, Navarra, Spain
  • +5 more
Mar 29, 2022

Melanoma Stage Iv, Melanoma Stage Iii, Advanced Cancer Trial in Spain (Daily Clinical Practice)

Recruiting
  • Melanoma Stage Iv
  • +2 more
  • Daily Clinical Practice
  • Alcoy, Alicante, Spain
  • +38 more
Mar 9, 2022

Advanced Cancer Trial in Worldwide (Ipilimumab, BMS-986218, Nivolumab)

Recruiting
  • Advanced Cancer
  • Ipilimumab
  • +2 more
  • Aurora, Colorado
  • +55 more
Mar 7, 2022

Advanced Cancer Trial in Worldwide (BMS-986178, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • Aurora, Colorado
  • +21 more
Dec 25, 2021

Advanced Cancer Trial in Worldwide (Nivolumab, Daratumumab)

Completed
  • Advanced Cancer
  • Nivolumab
  • Daratumumab
  • Long Beach, California
  • +19 more
Jul 2, 2021

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Neuroendocrine Tumors, Advanced Cancer Trial in Worldwide (Axitinib, Sandostatin LAR, Placebo)

Unknown status
  • Neuroendocrine Tumors
  • Advanced Cancer
  • Marburg, Germany
  • +25 more
Feb 1, 2021

Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,

Completed
  • Advanced Cancer
  • Advanced Malignancies
  • Gilbert, Arizona
  • +46 more
Jan 23, 2020

Advanced Cancer Trial in Madrid (Belinostat)

Completed
  • Advanced Cancer
  • Madrid, Spain
    Hospital Universitario Madrid Sanchinarro
Dec 31, 2019

Pain, Advanced Cancer Trial in Worldwide (Nabiximols, Placebo (GA-0034))

Completed
  • Pain
  • Advanced Cancer
  • East Melbourne, Australia
  • +64 more
Mar 23, 2018

Advanced Cancer, Ovarian Cancer, Endometrial Cancer Trial in Spain (PM01183 + olaparib)

Unknown status
  • Advanced Cancer
  • +3 more
  • PM01183 + olaparib
  • Córdoba, Andalucía, Spain
  • +5 more
Jun 21, 2017